Stone Adam Leo
SEC-identified person · CIK 1727440 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Immatics N.V. IMTX | Director | filed 2026 - 2026 |
| Solid Biosciences, LLC SLDB | Director | filed 2018 - 2026 |
| Adagio Medical Holdings, Inc. ADGM | Officer | filed 2024 - 2024 |
| Arya Sciences Acquisition Corp IV ARYD | Director · Chief Executive Officer | filed 2021 - 2024 |
| Perceptive Capital Solutions Corp PCSC | Director · Chief Executive Officer | filed 2024 - 2024 |
| Lianbio LIAN | Director · Interim CEO | filed 2021 - 2024 |
| Arya Sciences Acquisition Corp V ARYE | Director · Chief Executive Officer | filed 2021 - 2021 |
| Nautilus Biotechnology, Inc. [NAUT] | Director · Chief Executive Officer | filed 2020 - 2020 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director · Chief Executive Officer | filed 2020 - 2020 |
| Arya Sciences Acquisition Corp. ARYA | Director · Chief Executive Officer | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.